Compare Torrent Pharma with Lupin - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA LUPIN TORRENT PHARMA/
LUPIN
 
P/E (TTM) x 42.5 -66.1 - View Chart
P/BV x 9.2 3.1 296.2% View Chart
Dividend Yield % 1.1 0.7 157.9%  

Financials

 TORRENT PHARMA   LUPIN
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-21
LUPIN
Mar-21
TORRENT PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs3,0401,122 271.0%   
Low Rs1,933576 335.8%   
Sales per share (Unadj.) Rs473.0334.2 141.5%  
Earnings per share (Unadj.) Rs74.027.0 273.6%  
Cash flow per share (Unadj.) Rs112.946.6 242.2%  
Dividends per share (Unadj.) Rs35.006.50 538.5%  
Avg Dividend yield %1.40.8 183.8%  
Book value per share (Unadj.) Rs344.9300.1 115.0%  
Shares outstanding (eoy) m169.22453.68 37.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x5.32.5 207.0%   
Avg P/E ratio x33.631.4 107.1%  
P/CF ratio (eoy) x22.018.2 121.0%  
Price / Book Value ratio x7.22.8 254.9%  
Dividend payout %47.324.0 196.8%   
Avg Mkt Cap Rs m420,798385,072 109.3%   
No. of employees `000NANA-   
Total wages/salary Rs m14,39628,259 50.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m80,048151,630 52.8%  
Other income Rs m7571,363 55.6%   
Total revenues Rs m80,806152,993 52.8%   
Gross profit Rs m24,66625,669 96.1%  
Depreciation Rs m6,5788,874 74.1%   
Interest Rs m3,5831,406 254.7%   
Profit before tax Rs m15,26316,751 91.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,7444,485 61.2%   
Profit after tax Rs m12,51912,266 102.1%  
Gross profit margin %30.816.9 182.0%  
Effective tax rate %18.026.8 67.1%   
Net profit margin %15.68.1 193.3%  
BALANCE SHEET DATA
Current assets Rs m55,232139,864 39.5%   
Current liabilities Rs m48,91684,361 58.0%   
Net working cap to sales %7.936.6 21.6%  
Current ratio x1.11.7 68.1%  
Inventory Days Days1469 20.8%  
Debtors Days Days7108 6.4%  
Net fixed assets Rs m81,29894,439 86.1%   
Share capital Rs m846907 93.3%   
"Free" reserves Rs m57,526135,229 42.5%   
Net worth Rs m58,372136,136 42.9%   
Long term debt Rs m29,633161 18,382.6%   
Total assets Rs m136,530234,302 58.3%  
Interest coverage x5.312.9 40.7%   
Debt to equity ratio x0.50 42,872.3%  
Sales to assets ratio x0.60.6 90.6%   
Return on assets %11.85.8 202.1%  
Return on equity %21.49.0 238.0%  
Return on capital %21.413.3 160.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m21,53951,027 42.2%   
Fx outflow Rs m7,13621,081 33.9%   
Net fx Rs m14,40329,946 48.1%   
CASH FLOW
From Operations Rs m20,10718,218 110.4%  
From Investments Rs m-4,494-12,396 36.3%  
From Financial Activity Rs m-16,561-18,853 87.8%  
Net Cashflow Rs m-893-13,031 6.8%  

Share Holding

Indian Promoters % 71.3 46.5 153.1%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 20.6 40.4 50.9%  
FIIs % 11.6 15.3 76.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.8 53.2 54.1%  
Shareholders   67,205 361,862 18.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   SUN PHARMA    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    CADILA HEALTHCARE    



Today's Market

SGX Nifty Down 32 Points, Nazara Tech's Acquisition in Ad Tech Company, boAt-Dixon Technologies form JV, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a weak note yesterday. Benchmark indices witnessed heavy selling in the fag-end of the session as weak global cues.

Related Views on News

LUPIN 2020-21 Annual Report Analysis (Annual Result Update)

Oct 19, 2021 | Updated on Oct 19, 2021

Here's an analysis of the annual report of LUPIN for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

Torrent Pharma Beats Expectations: Stock Gets a Boost (Views On News)

May 19, 2021

Key takeaways from Torrent Pharma's March quarter results.

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Jan 19, 2022 09:22 AM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS